|国家科技期刊平台
首页|期刊导航|陕西医学杂志|血清微小核糖核酸-133a、微小核糖核酸-126、髓系细胞表达触发受体-1、肺表面活性蛋白A表达水平与脓毒症并发急性呼吸窘迫综合征风险及预后关系

血清微小核糖核酸-133a、微小核糖核酸-126、髓系细胞表达触发受体-1、肺表面活性蛋白A表达水平与脓毒症并发急性呼吸窘迫综合征风险及预后关系OACSTPCD

Relationship between the expression levels of serum miR-133a,miR-126,TREM-1 and SP-A and the risk and prognosis of ARDS complicated with sepsis

中文摘要英文摘要

目的:研究血清微小核糖核酸-133a(miR-133a)、微小核糖核酸-126(miR-126)、髓系细胞表达触发受体-1(TREM-1)、肺表面活性蛋白A(SP-A)表达水平与脓毒症并发急性呼吸窘迫综合征(ARDS)风险及预后的关系.方法:将248例脓毒症患者根据其是否发生ARDS分为无ARDS组(97例)和ARDS组(151例),统计两组血清miR-133a、miR-126、TREM-1、SP-A表达水平;分别根据脓毒症并发ARDS患者病情严重程度及入院后28 d预后情况将其分为轻度组(51例)、中度组(73例)、重度组(27例)及存活组(122例)、死亡组(29例),比较不同病情严重程度及预后脓毒症并发ARDS患者血清miR-133a、miR-126、TREM-1、SP-A表达水平.采用受试者工作特征曲线(ROC)分析血清miR-133a、miR-126、TREM-1、SP-A对脓毒症并发ARDS患者预后的预测价值.结果:ARDS组血清miR-133a、miR-126、TREM-1表达水平高于无ARDS组,血清SP-A表达水平低于无ARDS组(均P<0.05).轻度组、中度组、重度组血清miR-133a、miR-126、TREM-1表达水平呈升高趋势,血清SP-A表达水平呈降低趋势,组间比较差异具有统计学意义(均P<0.05).死亡组血清miR-133a、miR-126、TREM-1表达水平高于存活组,血清SP-A表达水平低于存活组(均P<0.05).血清miR-133a、miR-126、TREM-1、SP-A联合预测脓毒症并发ARDS患者预后的曲线下面积(AUC)值高于四者单独检测(均P<0.05);敏感度比较,血清SP-A、TREM-1高于血清miR-133a、miR-126及联合检测,血清SP-A高于血清TREM-1,联合检测高于血清miR-133a、miR-126(均P<0.05);特异度比较,血清miR-133a高于血清TREM-1、SP-A及联合检测,血清miR-126、联合检测高于血清TREM-1、SP-A(均 P<0.05).结论:血清 miR-133a、miR-126、TREM-1、SP-A 表达水平与脓毒症并发 ARDS 患者病情的发生和发展均关系密切,四者联合对脓毒症并发ARDS患者预后具有较好的预测效果.

Objective:To investigate the relationship between the expression levels of serum microRNA-133a(miR-133a).microRNA-126(miR-126),myeloid cell expression triggering receptor-1(TREM-1),pulmonary surfac-tant protein A(SP-A)and the risk and prognosis of acute respiratory distress syndrome(ARDS)complicated by sepsis.Methods:248 patients with sepsis were divided into a group without ARDS(97 cases)and a group with ARDS(151 cases)according to whether they had ARDS.Serum expression levels of miR-133a,miR-126,TREM-1 and SP-A in the two groups were analyzed.According to the severity of sepsis complicated with ARDS and the prognosis 28 d after admission,the patients were divided into the mild group(51 cases),the moderate group(73 cases),the se-vere group(27 cases)and the survival group(122 cases),the death group(29 cases).To compare the expression levels of miR-133a,miR-126,TREM-1 and SP-A in serum of ARDS patients with sepsis complicated with different severity and prognosis.The predictive value of serum miR-133a,miR-126,TREM-1 and SP-A on the prognosis of ARDS patients with sepsis was analyzed by receiver operating characteristic curve(ROC).Results:The expression levels of miR-133a,miR-126 and TREM-1 in the non-ARDS group were higher than those in the ARDS group,and the expression level of SP-A in the ARDS group was lower than that in the non-ARDS group(all P<0.05).The ex-pression levels of serum miR-133a,miR-126 and TREM-1 in the mild groups,the moderate groups and the severe groups were increased,while the expression level of serum SP-A was decreased(all P<0.05).The expression levels of serum miR-133a,miR-126 and TREM-1 in the death group were higher than those in the survival group,and the expression level of serum SP-A was lower than that in the survival group(all P<0.05).The area under the curve(AUC)value of serum miR-133a,miR-126,TREM-1 and SP-A combined to predict prognosis of ARDS patients with sepsis was higher than that of the four alone(all P<0.05).Sensitivity comparison showed that serum SP-A and TREM-1 were higher than serum miR-133a,miR-126 and combination,and serum SP-A was higher than serum TREM-1 and combined with serum miR-133a and miR-126(all P<0.05).The specificity of serum miR-133a was higher than that of serum TREM-1,SP-A and combination,and that of serum miR-126 and combination was higher than that of serum TREM-1 and SP-A(all P<0.05).Conclusion:The expression levels of serum miR-133a,miR-126,TREM-1 and SP-A are closely related to the occurrence and development of sepsis complicated with ARDS patients,and the combination of the four have a good predictive effect on the prognosis of sepsis complicated with ARDS patients.

苏一星;袁华;周守志;黄小明;夏晓华

昆山市第一人民医院急诊医学科,江苏昆山 215301

临床医学

脓毒症急性呼吸窘迫综合征微小核糖核酸-133a微小核糖核酸-126髓系细胞表达触发受体-1肺表面活性蛋白A预后

Sep sisAcute respiratory distress syndromemicroRNA-133amicroRNA-126Myeloid cells ex-press trigger receptor-1Pulmonary surfactant protein APrognosis

《陕西医学杂志》 2024 (007)

978-982 / 5

江苏省医院协会医院管理创新专项研究课题(JSYGY-3-2021-JZ65)

10.3969/j.issn.1000-7377.2024.07.025

评论